Predicting Prostate Cancer Recurrence with p27Kip1 Protein Levels
Author Information
Author(s): Kuczyk M, Machtens S, Hradil K, Schubach J, Christian W, Knüchel R, Hartmann J, Bokemeyer C, Jonas U, Serth J
Primary Institution: Hannover University Medical School
Hypothesis
Decreased expression of the p27Kip1 protein may predict recurrence-free and long-term survival in prostate cancer patients.
Conclusion
Loss of p27Kip1 protein expression is associated with a higher risk of recurrence in prostate cancer patients.
Supporting Evidence
- 33% of patients with low p27Kip1 expression developed recurrent disease.
- 23% of patients with retained p27Kip1 expression developed recurrent disease.
- Median recurrence-free survival was significantly lower for patients with low p27Kip1 expression.
Takeaway
If prostate cancer patients have low levels of a protein called p27Kip1, they might have a higher chance of their cancer coming back.
Methodology
The study analyzed 95 prostate cancer specimens for p27Kip1 protein expression and its correlation with recurrence-free survival.
Limitations
The study did not find a correlation between p27Kip1 expression and long-term survival, indicating a need for further research.
Participant Demographics
Patients undergoing radical prostatectomy, aged between 1981 and 1992.
Statistical Information
P-Value
0.02
Statistical Significance
p=0.02
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website